Development Level

Tchem 3 | 1,890
Tbio 1 | 10,625
Tclin 1 | 602

Disease

Alzheimer's disease 5 | 644
Asthma 5 | 349
Cancer 5 | 2,346
diabetes mellitus 5 | 1,663
Cerebrovascular disease 4 | 231
Hypertension 4 | 287
Neuropathy 4 | 210
Obesity 4 | 616
psoriasis 4 | 6,685
Allergic hypersensitivity disease 3 | 123
Arthritis 3 | 248
Cocaine-Related Disorders 3 | 88
Dermatitis 3 | 107
Endometriosis 3 | 535
Glaucoma 3 | 134
Heart disease 3 | 279
Huntington's disease 3 | 72
Hyperactive behavior 3 | 31
Hyperglycemia 3 | 120
Inflammation 3 | 109
Inflammatory bowel disease 3 | 142
Rhinitis 3 | 46
Schizophrenia 3 | 501
atypical teratoid / rhabdoid tumor 3 | 4,369
cystic fibrosis 3 | 1,665
glioblastoma 3 | 5,572
pediatric high grade glioma 3 | 2,712
Acute kidney injury 2 | 65
Adenoma 2 | 165
Alcohol dependence 2 | 107
Anxiety Disorders 2 | 37
Atherosclerosis 2 | 275
Autonomic neuropathy 2 | 21
Bronchitis, Chronic 2 | 9
Collagen disease 2 | 25
Complex regional pain syndrome 2 | 12
Coronary artery disease 2 | 240
Dementia 2 | 129
Diabetes Mellitus, Experimental 2 | 106
Diabetes Mellitus, Non-Insulin-Dependent 2 | 157
Diabetic Nephropathy 2 | 37
Diabetic Retinopathy 2 | 53
Epilepsy 2 | 346
Epilepsy, Temporal Lobe 2 | 23
Hepatitis C 2 | 90
Hereditary hemorrhagic telangiectasia 2 | 14
Hypersensitivity reaction type II disease 2 | 235
Kidney Failure, Chronic 2 | 45
Kidney disease 2 | 396
Liver Cirrhosis 2 | 101
Liver Cirrhosis, Experimental 2 | 108
Liver disease 2 | 219
Lung disease 2 | 132
Lung diseases 2 | 48
Major Depressive Disorder 2 | 106
Memory Disorders 2 | 36
Migraine 2 | 79
Multiple Sclerosis 2 | 498
Neoplasm Metastasis 2 | 138
Neurodegenerative disease 2 | 383
Osteoporosis 2 | 257
Pain agnosia 2 | 99
Parkinson's disease 2 | 364
Periodontal disease 2 | 37
Peripheral Neuropathy 2 | 303
Peripheral vascular disease 2 | 90
Phaeochromocytoma 2 | 20
Portal hypertension 2 | 21
Prostatic Neoplasms 2 | 471
Proteinuria 2 | 63
Retinal detachment 2 | 33
Seizures 2 | 95
Squamous cell carcinoma 2 | 94
Status Epilepticus 2 | 85
Urticaria 2 | 53
medulloblastoma 2 | 1,524
osteosarcoma 2 | 7,933
pancreatic cancer 2 | 2,300
pilocytic astrocytoma 2 | 3,086
posterior fossa group A ependymoma 2 | 1,511
primary pancreatic ductal adenocarcinoma 2 | 1,271
ulcerative colitis 2 | 2,087
Acute Lung Injury 1 | 18
Amnesia 1 | 17
Anhidrosis 1 | 12
Cerebral Hemorrhage 1 | 27
Chronic fatigue syndrome 1 | 29
Hereditary Sensory and Autonomic Neuropathies 1 | 4
Hyperinsulinism 1 | 63
Kidney failure 1 | 39
Lewy Body Disease 1 | 19
Lung Injury 1 | 20
Neoplasms, Experimental 1 | 33
Neurodegenerative Disorders 1 | 37
POEMS syndrome 1 | 6
Peyronie's disease 1 | 8
Retinopathy of prematurity 1 | 21
Schistosomiasis 1 | 38
Ureteral disease 1 | 23
Uveitis 1 | 103

Tissue

Endocrine System 5 | 18,512
Female tissues 5 | 18,647
Nervous System 5 | 18,561
Blood and immune system 4 | 17,995
Cardiovascular System 4 | 17,958
Digestive Tract 4 | 18,473
Liver and Pancreas 4 | 18,136
Male tissues 4 | 17,969
Respiratory system 4 | 17,484
Skin and soft tissues 4 | 18,115
Urinary Tract 4 | 18,444

Target Family

Non-IDG 5 | 11,971

Grant Application

5R01HL068009-03 5 | 5
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Pro-neuropeptide Y NPY Tbio Non-IDG -3.81741 7285.3 401
Vascular endothelial growth factor A VEGFA Tclin Non-IDG -4.21581 17832.7 1361
Beta-nerve growth factor NGF Tchem Non-IDG -3.99294 10626.8 510
Transforming growth factor beta-1 TGFB1 Tchem Non-IDG -4.32707 20956.6 961
Neuropeptide S NPS Tchem Non-IDG -3.89942 7090.5 86